About Galenica
Galenica is a publicly listed company based in Geneve (Switzerland) founded in 1927. Pharmaceutical and OTC products are manufactured by Galenica. It operates on a Managed Services model. The company has 6,120 employees. Galenica has completed 8 acquisitions, including Aquantic, Aspreva Pharmaceutics and BMC SSI. Its website galenica.com draws about 56 thousand monthly visits. Galenica offers products and services including Integrated Healthcare Solutions. Its focus areas include Integrated Healthcare and Healthcare Networks. Its legal entity is Galenica Ltd.
Company details
Galenica is established as a leader in the Swiss healthcare market through its extensive network of over 20 Business Units. Healthcare needs of patients and customers are addressed in a seamless, efficient, and personalized manner. The strongest partnerships in the Swiss healthcare sector are maintained to shape the future of healthcare. Significant growth in sales and profitability is achieved, as reported in the first half of 2025.
- Headquarters Geneve, Switzerland
- Employees 6,120
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phone•••• ••••
- Website galenica.com/en
- Social LinkedIn Facebook Instagram
- Legal Name Galenica Ag
- Annual Revenue$5.22 B (USD)5.47as on Dec 31, 2025
- Net Profit$228.47 M (USD)-1.01as on Dec 31, 2025
- EBITDA$427.89 M (USD)8.99as on Dec 31, 2025
- Latest Funding Round$735.54M (USD), Post-IPO
Mar 2015
- Investors
- Employee Count6,120
- Investments & AcquisitionsAquantic
& 7 more
Products & Services of Galenica
Galenica offers a comprehensive portfolio of products and services, including Integrated Healthcare Solutions.
Healthcare needs are met with personalized, efficient solutions.
Funding Insights of Galenica
- Total Rounds 3
- Last Round Post-IPO — $735.54M
- Investors Count 1
All 3 funding rounds of Galenica with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2015 | $735.54M | Post-IPO | – | – | – |
| Nov 2003 | $156.05M | Debt – Conventional | – | – | – |
| Jun 1999 | Post-IPO | – | – |
1 investors in total: 1 institutional.
Investors in Galenica
Galenica has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Alliance Boots.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Chain of pharmacies | 1848 | allianceboots.com | Deerfield, United States |
Investor details for Galenica
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Galenica
135 people are tracked at Galenica (33 in leadership, 5 in board & advisors, 97 in team); the tracked headcount is 6,120.
| Name | Role | Group |
|---|---|---|
Steve Mertens | Head Of Supply Chain And Stock Management | Leadership |
Marc Werner | CEO | Leadership |
Daniele Madonna | Chief Healthcare Officer | Leadership |
Jürg Pauli | Chief Transformation Officer | Leadership |
Andreas Kempf | Head Of Compensation & Benefits | Leadership |
Thomas Szuran | Chief Products & Marketing Officer | Leadership |
Andreas Koch | Head, Wholesale & Logistics | Leadership |
Stephan Mignot | Head Of Pharmacies Marketing, Member Of The Executive Committee | Leadership |
Florian Urech | Head Of Investor Relations & Corporate Finance | Leadership |
Arianne Hasler | Chief People & Culture | Leadership |
Dr. Fabian Sommerrock | Head Business Development & Cooperations | Leadership |
Jocelyne Caille | Head Of Marketing At Winconcept | Leadership |
Baltisar Oswald | Head Of Software Engineering | Leadership |
Lukas Ackermann | Chief IT & Digital Services Officer | Leadership |
Dr. Thomas F. Szuran | Deputy CEO Galenica Group | Leadership |
Patricia Grämiger | Head Recruiting & Employer Branding | Leadership |
Marianne Ellenberger | Head, Human Resources | Leadership |
Douglas Andrews | Chief Information Security Officer (ciso) | Leadership |
Monika Hofmann | Head Of HR Business Partner & Consulting | Leadership |
André Schmutz | Head Vaccination Services Galenica | Leadership |
115 more people are available in the full profile.
Complete people profiles for Galenica
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Galenica
Galenica is a publicly listed company on the SIX with ticker symbol GALE in Switzerland, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date07 Apr 2017
- Listed onBX: GALE
- Listed entityGalenica AG
- Exchange sectorDistribution services
- ISINCH0360674466
- Share price81.75 CHF (-1.09% on the day) · 2026-05-11
- Market capitalisation4,118,203,175.00 CHF
- Price to earnings22.5
- EPS (diluted, trailing year)3.63 CHF
- Dividend yield3.02%
- Volume (last session)17,552
- Analyst consensusNeutral
Financials of Galenica
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 4.14B CHF | 181.1M CHF | 339.2M CHF |
| 2024 | 3.92B CHF | 182.9M CHF | 311.2M CHF |
| 2023 | 3.75B CHF | 173.6M CHF | 288.3M CHF |
| 2022 | 3.59B CHF | 165.1M CHF | 282.2M CHF |
| 2021 | 3.83B CHF | 167.7M CHF | 284.7M CHF |
Detailed financial statements for Galenica
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Galenica
Galenica has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Aquantic, Aspreva Pharmaceutics and BMC SSI.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Company offering laboratory analysis and diagnostics services | laborteam.ch | Goldach, Switzerland | 2001 | Jul 2025 | •••• | |
Herbal medicines are manufactured and distributed by PADMA. | padma.ch | Wetzikon, Switzerland | 1969 | Jan 2023 | •••• | |
Software development and consulting services are provided by Aquantic. | aquantic.ch | Berlin, Germany | 2000 | Jul 2022 | •••• | |
Digital solutions for in-patient care management are provided. | lifestage-solutions.ch | Otelfingen, Switzerland | 2014 | Sep 2021 | •••• | |
Non-absorbed polymeric drugs for cardiovascular and renal diseases are developed. | relypsa.com | Redwood, United States | 2007 | Jul 2016 | $1.53B | |
Prescription-based medication delivery and adherence monitoring are provided. | mediservice.com | Zuchwil, Switzerland | 1996 | Oct 2007 | •••• | |
Medicines for rare autoimmune disorders were developed by Aspreva Pharmaceutics. | aspreva.com | Starnberg, Germany | 2001 | Oct 2007 | $943M | |
IT service suite solutions are provided for enterprise needs. | bmcssi.ch | 1985 | Jun 2007 | •••• |
Complete acquisition details for Galenica
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Galenica
12 dated milestones of Galenica across 98 years, from founding to its latest funding, stage changes and deals.
- Founded Galenica is founded.
- Funding First funding round.
- Acquisition Acquires BMC SSI.
- Acquisition Acquires Aspreva Pharmaceutics.
- Acquisition Acquires MediService.
- Funding Latest funding round, Post-IPO, of $735.5M.
- Acquisition Acquires Relypsa.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Lifestage Solutions.
- Acquisition Acquires Aquantic.
- Acquisition Acquires PADMA.
- Acquisition Acquires labor team.
Web traffic of Galenica
The website of Galenica (galenica.com) receives about 56.1K visits a month and ranks #459,247 among all websites worldwide, #437 in Biotechnology and Pharmaceuticals.
- Monthly visits56.1K
▼ 13.3% vs previous month
- Unique visitors19.3K
per month
- Global rank#459,247
among all websites
- Category rank#437
Health · Biotechnology and Pharmaceuticals
- Bounce rate38%
- Pages per visit3.4
- Average visit2 min 53 sec
- DevicesDesktop 47% · Mobile 53%
Websites whose visitors overlap most with Galenica. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| viforpharma.com | 100% | View details | |||
farmexpert.ro | farmexpert.ro | 91% | – | ||
gzmpc.com | gzmpc.com | 91% | #1,684,172 | – | |
verfora.ch | verfora.ch | 81% | #876,413 | – | |
| oktal-pharma.hr | 60% | 30.9K | #939,210 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Galenica
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Galenica
Complete news archive for Galenica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Galenica
Galenica was founded in 1927 and raised its 1st funding round 72 years after it was founded.
Galenica is headquartered in Geneve, Switzerland. It is registered at Geneve, Geneve, Switzerland.
Galenica has 6,120 employees.
Annual revenue of Galenica is $5.22B as on Dec 31, 2025.
Galenica is established as a leader in the Swiss healthcare market through its extensive network of over 20 Business Units. Healthcare needs of patients and customers are addressed in a seamless, efficient, and personalized manner. The strongest partnerships in the Swiss healthcare sector are maintained to shape the future of healthcare. Significant growth in sales and profitability is achieved, as reported in the first half of 2025.
Galenica offers Integrated Healthcare Solutions.
Yes, Galenica is publicly traded on SIX under the ticker symbol GALE.
Galenica has made 8 acquisitions, including Aquantic, Aspreva Pharmaceutics, and BMC SSI.
Galenica has 1 investor. Key investors include Alliance Boots.
Galenica operates through Galenica Ltd..